Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Glycomics or Glycobiology Market Set To Climb From $2.49 Billion In 2026 To $4.66 Billion By 2030
The glycomics or glycobiology market size has seen rapid expansion in recent years. This market is anticipated to increase from $2.13 billion in 2025 to $2.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. The historical growth of this market can be linked to improvements in carbohydrate chemistry, the expansion of life sciences research, increased academic research funding, early efforts in biomolecule characterization, and the development of new analytical instruments.
The glycomics or glycobiology market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $4.66 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.0%. This significant growth during the forecast period is primarily attributed to the broadening scope of precision medicine, increased investments in pharmaceutical research and development, a rising demand for biomarker discovery, technological advancements in mass spectrometry, and an escalation in translational research efforts. Concurrently, major trends expected during this period include the wider application of glycan-based biological research, enhanced utilization of glycomics in drug discovery, a growing requirement for sophisticated glycan analysis tools, the progressive incorporation of glycobiology into diagnostics, and a surge in cooperative ventures between academic institutions and industry.
Get A Free Sample Report With In-Depth Market Insights:
Glycomics or Glycobiology Market Growth Catalysts And Demand Drivers
The escalating need for pharmaceutical goods is projected to fuel the expansion of the glycomics or glycobiology market in the future. Pharmaceutical items denote drugs or medicines specifically created to diagnose, avert, treat, or alleviate illnesses or health issues in humans or animals. Glycomics and glycobiology play a crucial role in pharmaceutical progress by offering understanding into disease processes, pinpointing therapeutic objectives, and refining the formulation and effectiveness of medications for various medical ailments. As an illustration, in February 2024, the US-based non-profit, Personalized Medicine Coalition, reported that in 2023, the FDA sanctioned 16 novel personalized therapies for patients with rare diseases, a significant rise from six in 2022. Among these newly approved personalized treatments for 2023 were also seven drugs for cancer and three for other conditions and diseases. Consequently, the rising requirement for pharmaceutical products is propelling the growth of the glycomics or glycobiology market.
Glycomics or Glycobiology Market Segment Outlook: Which Categories Are Growing Fastest?
The glycomics or glycobiology market covered in this report is segmented –
1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories
Subsegments:
1) By Enzymes: Glycosidases, Glycosyltransferases, Sialidases
2) By Kits: Glycan Analysis Kits, Glycobiology Research Kits
3) By Reagents And Chemicals: Monosaccharides, Oligosaccharides, Chemical Modifiers
4) By Instruments: Mass Spectrometers, Chromatography Systems, Imaging Systems
5) By Carbohydrates: Natural Carbohydrates, Synthetic Carbohydrates
Glycomics or Glycobiology Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the glycobiology market are concentrating on developing innovative solutions, such as glycan-display platforms, to accelerate the discovery of carbohydrate-based therapeutics and vaccines. Glycan-display platforms are technologies that present diverse sugar molecules (glycans) on surfaces or scaffolds to study their interactions with proteins, cells, or pathogens for drug and vaccine development. For instance, in October 2024, CD BioGlyco, a US-based biotechnology company, introduced its Glycan Display Platform. This advanced, integrated glycan-display technology provides multiple modalities, including traditional glycan arrays, cell-based glycan display, neoglycolipid (NGL) display, liquid glycan arrays (LiGA), glyco-phage display, and de novo glycan display, supporting a wide range of glycobiology research applications such as drug discovery and glycan-protein interaction studies. This platform utilizes synthesized or natural glycans, immobilizing or presenting them on carriers like lipids, phage particles, or engineered cells, enabling researchers to explore glycan binding properties under various contexts, for example, fluid versus immobilized or monovalent versus multivalent. Such capabilities facilitate high-throughput screening, fine-tuned control over glycan density or presentation format, and offer greater physiological relevance compared to traditional glycan microarrays, which typically immobilize glycans on rigid surfaces.
Glycomics or Glycobiology Market Leading Companies And Competitive Benchmarking
Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.
View The Full Glycomics or Glycobiology Market Report:
Glycomics or Glycobiology Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the glycomics or glycobiology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









